Related Experiment Video

Updated: Jun 18, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention

A van der Graaf1, J J P Kastelein1, A Wiegman2,3

  • 1Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Journal of Inherited Metabolic Disease
|November 10, 2009
PubMed

Insights

Children with familial hypercholesterolaemia (FH) benefit from early statin therapy to lower low-density lipoprotein cholesterol (LDL-C) and prevent premature cardiovascular disease (CVD). Studies confirm statins are safe and effective for managing FH in pediatric patients.

Area of Science:

  • Pediatrics
  • Cardiology
  • Genetics

Background:

  • Familial hypercholesterolaemia (FH) causes severely elevated low-density lipoprotein cholesterol (LDL-C) in children, increasing premature cardiovascular disease (CVD) risk.
  • Early identification and intervention are crucial for preventing long-term CVD complications.

Purpose of the Study:

  • To review the efficacy and safety of lipid-lowering therapies, particularly statins, in children diagnosed with FH.
  • To highlight the role of early intervention in managing pediatric FH and preventing CVD.

Main Methods:

  • Review of studies published in the past decade assessing statin efficacy and safety in pediatric FH.
  • Analysis of clinical trial data on lipid-lowering effects and tolerability of statins in children.

Main Results:

  • Statins have demonstrated good tolerability, safety, and effectiveness in lowering LDL-C levels in children with FH.
  • Lipid-lowering therapy, including statins, can inhibit the atherosclerotic process.

Conclusions:

  • Statins play a pivotal role in the treatment of children with FH, complementing lifestyle modifications.
  • Early initiation of statin therapy is essential for preventing premature cardiovascular disease in pediatric FH patients.

More Related Videos

High-Density Lipoprotein-Specific Phospholipid Efflux Assay07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...